BlueLinx Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BlueLinx stock.
View analyst ratings for BlueLinx or view top-rated stocks.

Wall Street analysts have given BlueLinx a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BlueLinx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

BlueLinx saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 770,100 shares, an increase of 33.8% from the June 15th total of 575,500 shares. Based on an average daily volume of 243,200 shares, the short-interest ratio is currently 3.2 days. Currently, 8.5% of the shares of the stock are short sold.
View BlueLinx's Short Interest.

BlueLinx is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for BlueLinx.

BlueLinx will be holding an earnings conference call on Wednesday, August 4th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 844-512-2921 with passcode "13721148".

BlueLinx Holdings Inc. (NYSE:BXC) announced its quarterly earnings results on Monday, May, 3rd. The construction company reported $6.28 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.09 by $4.19. The construction company earned $1.03 billion during the quarter. BlueLinx had a net margin of 4.15% and a trailing twelve-month return on equity of 268.95%.
View BlueLinx's earnings history.

BlueLinx's stock was trading at $5.53 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BXC shares have increased by 656.4% and is now trading at $41.83.
View which stocks have been most impacted by COVID-19.

4 equities research analysts have issued 12-month target prices for BlueLinx's shares. Their forecasts range from $25.00 to $85.00. On average, they expect BlueLinx's stock price to reach $54.00 in the next twelve months. This suggests a possible upside of 29.1% from the stock's current price.
View analysts' price targets for BlueLinx or view top-rated stocks among Wall Street analysts.

56 employees have rated BlueLinx CEO Mitch Lewis on Glassdoor.com. Mitch Lewis has an approval rating of 49% among BlueLinx's employees. This puts Mitch Lewis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to BlueLinx include Fastenal (FAST), United Rentals (URI), W.W. Grainger (GWW), Watsco (WSO), WESCO International (WCC), MSC Industrial Direct (MSM), Air Lease (AL), Beacon Roofing Supply (BECN), Applied Industrial Technologies (AIT), GATX (GATX), Rush Enterprises (RUSHA), Textainer Group (TGH), Kaman (KAMN), H&E Equipment Services (HEES) and MRC Global (MRC).
View all of BXC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Maxar Technologies (MAXR), Civeo (CVEO), Nautilus (NLS), Sorrento Therapeutics (SRNE) and Hologic (HOLX).

BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC."

BlueLinx's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Hillsdale Investment Management Inc. (1.03%), Acuitas Investments LLC (0.29%), Cutler Group LP (0.00%), Exchange Traded Concepts LLC (0.13%), New York State Common Retirement Fund (0.08%) and Advisor Group Holdings Inc. (0.03%). Company insiders that own BlueLinx stock include Alexander S Averitt, Brian J Sasadu, Carol B Yancey, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC and Shyam K Reddy.
View institutional ownership trends for BlueLinx.

BXC stock was sold by a variety of institutional investors in the last quarter, including Acuitas Investments LLC, Hillsdale Investment Management Inc., Exchange Traded Concepts LLC, and Advisor Group Holdings Inc.. Company insiders that have sold BlueLinx company stock in the last year include Kim S Fennebresque, Mitchell B Lewis, and Nokomis Capital, LLC.
View insider buying and selling activity for BlueLinx or view top insider-selling stocks.

BXC stock was purchased by a variety of institutional investors in the last quarter, including Cutler Group LP, and New York State Common Retirement Fund. Company insiders that have bought BlueLinx stock in the last two years include Alexander S Averitt, Brian J Sasadu, Carol B Yancey, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, and Shyam K Reddy.
View insider buying and selling activity for BlueLinx or or view top insider-buying stocks.

Shares of BXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BXC stock can currently be purchased for approximately $41.83.

BlueLinx has a market capitalization of $396.13 million and generates $3.10 billion in revenue each year.

BlueLinx employs 2,100 workers across the globe.

The official website for BlueLinx is www.bluelinxco.com.

BlueLinx is headquartered at 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067.

BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The construction company can be reached via phone at 770-953-7000 or via email at [email protected]